Interview with the Innovators

Supported by BridgeBio

Joel N Buxbaum, MD
Molecular Medicine
The Scripps Research Institute
Chief Medical Officer
Protego Biopharma

The first video in the 9-part “Interview with the Innovators” series is titled “The Role of Transthyretin (TTR) in Normal Human Physiology.” In this video clip, Joel N. Buxbaum, MD, Professor Emeritus, Molecular Medicine, The Scripps Research Institute, and Chief Medical Officer (consulting), Protego Biopharma, discusses the principal, as well as, less defined mechanisms underlying the physiologic functions of TTR in healthy individuals. These learnings are key for the optimal understanding of disease states associated with abnormalities in TTR structure and function.

Related Items

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to receive: